Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Hisse Senetlerindeki Sıralama #19170
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Hisse Fiyatı
$1.62
Son senkronizasyon: 2026-08-25
Piyasa Değeri
$172.47M
Değişim (1 gün)
-3.57%
Değişim (1 yıl)
446.74%
Ülke
US
Ticaret Cypherpunk Technologies Inc. (CYPH)

Kategori

Cypherpunk Technologies Inc. (CYPH) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.94 - 2026-08-01

Gün sonu en düşük fiyat: $75.65 - 2017-01-01
Cypherpunk Technologies Inc. için hisse fiyatı geçmişi: 2017 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -31.92%
2025 -58.69%
2024 -5.41%
2023 -33.87%
2022 -82.32%
2021 38.52%
2020 121.83%
2019 -68.29%
2018 -56.56%
2017 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$770.45 7.08%
CH